4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) Stock Information | RedChip

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT)


$8.2700
N/A ( 0% ) 0.0K

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Market Data


Open


$8.2700

Previous close


$8.2700

Volume


0.0K

Market cap


$429.79M

Day range


$8.4110 - $8.5350

52 week range


$7.9000 - $36.2500

SEC Filings


Form Type Description Pages Date
10-k Annual reports 107 Feb 29, 2024
4 Insider transactions 1 Feb 29, 2024

Latest News